Advertisement
Screener

Semnur Pharmaceuticals, Inc. (SMNR) Deferred Tax Assets, Operating Loss Carryforwards, Domestic

2.5 / 5 stars · 2/4 Roast Me

Add as a preferred source on Google

Semnur Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic

Semnur Pharmaceuticals, Inc. (SMNR) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $166.20 million as of 2025-12-31, per its S-1 filed 2026-05-12.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-05-12

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $166.20M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Domestic
2025-12-31$166.20M
S-1 · filed 2026-05-12
Advertisement